These findings demonstrate that the identified gene dysregulation is unique to Tet2-mutant cells within a Jak2V617F-mutant milieu and not a generalized feature of HSPCs exposed to MPN cells. This evidence concerns the gene TET2 and myeloproliferative disorder.